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S2 Diabetic NephropathyAngiotensin Receptor Blocker normally. Based on whether the renal biopsy
speciments were deposited by complement 3, the patients were divided
into two groups. This study selected eGFR<45 ml/min/1.73 m2 or dialysis
as end events. At the end of follow-up, the difference of serum creatinine
and 2 year renal survival rates were compared.
Results: The group with complement 3 deposited has higher 24-hour protein-
uria (3.4  1.6 vs 4.5  2.0, PZ 0.039), however, clinical data of patients at
baseline showed no differences in systolic and diastolic blood pressures, BMI,
FBG, HbA1c, Albumin and sCr between the two groups. More than sixty pre-
sents subjects (87%) received renin angiotensin system blocker. After two
years of follow-up, 29.2%(21/78) patients progress to eGFR < 45 mL/min/
1.73 m2. And the cumulative progression rate by two years was 38.7%(12/
31) for patients in the C3 positive group and 19.1%(9/47) for patients in
the C3 negative group. The survival of stable renal function during the study
was similar between two groups (PZ 0.052). In the subgroup analysis of pa-
tients without nephrotic syndrome, patients in the C3 positive group were
less likely to progress to eGFR < 45 mL/min/1.73 m2 than those in the C3
negative group (P Z 0.007). In a multivariate model, we found C3 positive
(HR, 2.726; 95% CI, 1.108e6.703) was a risk factor for progressive renal
function.
Conclusion: The deposition of complement 3 has a certain degree influence
on the prognosis of nodular sclerosis of diabetic nephropathy.
Fig. 5. Survival based on C3. (A) Total patients. (B) Patients without
nephrotic syndrome. (C) Patients with nephrotic syndrome.http://dx.doi.org/10.1016/j.hkjn.2015.08.007
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Objective: The release of Platelet microparticles (PMPs) is considered to be
proinflammatory and eliciting cytokine reponses. This study was undertaken
to investigate the role of PMPs in glomerular endothelial injury in diabetic
nephropathy (DN).
Methods: Eight-week old male Sprague-Dawley rats were divided into three
groups: nondiabetic rats (control), streptozotocin-induced diabetic rats
(DM), and diabetic rats treated with Aspirin (DM+ Aspirin). The determina-
tion of PMPs was used by flow cytometry and confocal microscopy. The in-
flammatory cytokines released from PMPs was checked by protein
microarray contain a variety of inflammatory cytokines, immunohistochem-
ical staining, or Western blot. The glomerular endothelial injury was evalu-
ated through measuring the change of endothelial surface layer (ESL),
endothelial fenestration, cellular junction, and glomerular permeability by
electron microscope, immunofluorescence staining and Western blot. The
ratio of urinary microalbumin to creatinine (ACR) was detected by
enzyme-linked immunosorbent assay.
Results: Compared to the control, the serum level of PMPs was signifi-
cantly increased in DM rats, while it was reduced by Aspirin. Aspirin treat-
ment decreased the production of inflammatory cytokines in PMPs
suspension, blood serum and glomerulus. Using confocal microscopy, the
enhanced interaction between PMPs and glomerular endothelium was
observed in DM rat, which was inhibited by Aspirin. Interestingly, the
elevated PMPs and production of inflammatory cytokines from PMPs were
correlated with the glomerular endothelial injury by decreasing the ESLthickness and endothelial fenestration, destroying cellular junction,
increasing glomerulus permeability and the level of ACR in DM rats.
Decrease of serum PMPs and production of inflammatory cytokines by
Aspirin ameliorated the glomerular endothelial injury compared to the
DM group.
Conclusion: Elevated serum PMPs contributes to glomerular endothelial
injury in diabetic nephropathy through the release of inflammatory cyto-
kines from PMPs.http://dx.doi.org/10.1016/j.hkjn.2015.08.008
0036
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Objectives: Diabetic nephropathy (DN) is a dominant cause of end-stage
renal disease in China. The early diagnosis of DN has focused on measure-
ment of UAlb excretion rate, but it is not sensitive marker for DN patients
with inchoate injuries in glomeruli and renal tubules. This study thus aimed
to evaluate clinical significance of urinary tubular biomarkers in predicting
development of DN patients at early stage.
Methods: The study was performed on 92 diabetes mellitus with different
levels of UAlb and certain range of Scr (<106 mmol/L). According to albu-
min-to-creatinine ratio (ACR) in urine, all patients were categorized into 3
groups, normoalbuminuria (A) group, microalbuminuria (B) group and macro-
albuminuria (C) group. In addition to UAlb, Scr and ACR, levels of tubular
biomarkers including UNAG, URBP and UCysC in urine were tested respec-
tively before renal protective drugs intervention.
Results: Compared with A group, levels of UNAG, URBP and UCysC in B and C
groups were significantly different (P < 0.01). Along with UAlb, stepwise in-
creases in levels of UNAG, URBP and UCysC were detected respectively in B
and C groups. Moreover, in univariate analysis, there was immediate rele-
vance between UAlb, ACR and tubular biomarkers including UNAG
(r Z 0.706, P < 0.01; r Z 0.808, P < 0.001), URBP (r Z 0.687, P < 0.01;
r Z 0.701, P < 0.001) and UCysC (r Z 0.727, P < 0.01; r Z 0.790,
P < 0.001) in all groups. In addition, we found that UNAG was positively
correlated with URBP (r Z 0.652, P Z 0) and UCysC (r Z 0.785, P Z 0).
URBP was also definitely related to UCysC (r Z 0.673, P Z 0). Multivariate
logistic regression showed that body mass index and fasting blood glucose
were two predictive factors of increased UCysC.
Conclusion:Atearly stageofDN, increased levels ofUNAG,URBPandUCysCare
independently associated with UAlb, and these urinary tubular biomarkers
similar to UAlb may be widely used as practical targets in clinic in detecting
and managing DN, and predicting renal tubular damaged progression.http://dx.doi.org/10.1016/j.hkjn.2015.08.009
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Objective: Increasing evidence shows that non-coding RNAs play an impor-
tant role in kidney disease. Recently, we identified Smad3-dependent
lncRNAs related to renal fibrosis by high-throughput RNA-sequencing. In
this study, we investigated the role and therapeutic potential of
lncRNA_5318 in type-2 diabetic nephropathy (T2DN).
Methods: Expression of lncRNA_5318 in the diabetic kidney of db/db mice
was examined by real-time PCR. The role and therapeutic effect of
lncRNA_5318 on T2DN were determined by knocking down lncRNA_5318
from the diabetic kidney using an ultrasound-microbubble-mediated shRNA
